26d • General discussion
Curcumin Found to Outperform Pneumococcal Vaccines in Protecting Infants
Despite no evidence of its effectiveness to prevent disease, public health agencies and the medical community insist that infants and children between the ages of 2 and 12 months require up to four shots of the Pneumococcal Conjugate Vaccine (PCV). Now new research finds a substance in turmeric, curcumin, may outperform the vaccine in providing long lasting protection against potentially deadly lung damage in infants.
9
2 comments
Curcumin Found to Outperform Pneumococcal Vaccines in Protecting Infants
powered by
skool.com/mind-and-body-solutions-9844
The team at MBS is here to provide understanding, care, and empowerment as you move toward your healthiest self. Let us know how we can assist you!
Suggested communities
Powered by